Bazı Heterosiklik Bileşiklerin İyonlaşma/Protonasyon, Lipofilisite ve Çözünürlük Sabitlerinin Belirlenmesi
Öz
Anahtar Kelimeler
Kaynakça
- [1] Gaba, M., Singh, S., Mohan, C. 2014. Benzimidazole: an Emerging Scaffold for Analgesic and Anti-Inflammatory Agents. European Journal of Medicinal Chemistry, 76, 494-505.
- [2] Vitaku, E., Smith, D.T., Njardarson, J.T. 2014. Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals. Journal of Medicinal Chemistry, 57, 10257-10274.
- [3] Anand, K., Wakod, S. 2017. Development of Drugs Based on Benzimidazole Heterocycle: Recent Advancement and Insights. International Journal of Chemical Studies, 5(2), 350-362.
- [4] Verma, A., Joshi, S., Singh, D. 2013. Imidazole: Having Versatile Biological Activities. Journal of Chemistry, 2013, 1-12.
- [5] Ali, I., Lone, M.N., Aboul-Enein, H.Y. 2017. Imidazoles as Potential Anticancer Agents. Medicinal Chemistry Communications, 8, 1742-1773.
- [6] El Rashedy, A.A., Aboul-Enein, H.Y. 2013. Benzimidazole Derivatives as Potential Anticancer Agents. Mini-Reviews in Medicinal Chemistry, 13(3), 399-407.
- [7] Wan, H., Holmén, A.G., Wang, Y., Linbeg, W., Englund, M., Någård, M.B., Thompson, R.A. 2003. High-Throughput Screening of pKa Values of Pharmaceuticals by Pressure-Assisted Capillary Electrophoresis and Mass Spectrometry. Rapid Communications in Mass Spectrometry, 17(23), 2639-2648.
- [8] Brown, T.N., Mora-Diez, N. 2006. Computational Determination of Aqueous pKa Values of Protonated Benzimidazoles (Part 2). Journal of Physical Chemistry B, 110(41), 20546-20554.
Ayrıntılar
Birincil Dil
Türkçe
Konular
Mühendislik
Bölüm
Araştırma Makalesi
Yazarlar
Kader Poturcu
*
0000-0001-6485-4150
Türkiye
Ebru Çubuk Demiralay
Bu kişi benim
0000-0002-6270-7509
Türkiye
Yayımlanma Tarihi
25 Ağustos 2019
Gönderilme Tarihi
14 Nisan 2019
Kabul Tarihi
19 Ağustos 2019
Yayımlandığı Sayı
Yıl 2019 Cilt: 23 Sayı: 2